153 related articles for article (PubMed ID: 38194234)
1. Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS Trial.
Freret TS; Cohen JL; Gyamfi-Bannerman C; Kaimal AJ; Lorch SA; Wright JD; Melamed A; Clapp MA
JAMA Netw Open; 2024 Jan; 7(1):e2350830. PubMed ID: 38194234
[TBL] [Abstract][Full Text] [Related]
2. US Incidence of Late-Preterm Steroid Use and Associated Neonatal Respiratory Morbidity After Publication of the Antenatal Late Preterm Steroids Trial, 2015-2017.
Clapp MA; Melamed A; Freret TS; James KE; Gyamfi-Bannerman C; Kaimal AJ
JAMA Netw Open; 2022 May; 5(5):e2212702. PubMed ID: 35583868
[TBL] [Abstract][Full Text] [Related]
3. Post Antenatal Late Preterm Steroids trial: interrupted time series analysis of respiratory outcomes in twin and pregestational diabetes.
Onishi K; Huang JC; Saade GR; Kawakita T
Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101041. PubMed ID: 37290604
[TBL] [Abstract][Full Text] [Related]
4. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids.
Kearsey EOR; Been JV; Souter VL; Stock SJ
Am J Obstet Gynecol; 2022 Aug; 227(2):280.e1-280.e15. PubMed ID: 35341727
[TBL] [Abstract][Full Text] [Related]
5. Maternal Nativity and Preterm Birth.
Huang X; Lee K; Wang MC; Shah NS; Perak AM; Venkatesh KK; Grobman WA; Khan SS
JAMA Pediatr; 2024 Jan; 178(1):65-72. PubMed ID: 37955913
[TBL] [Abstract][Full Text] [Related]
6. Preterm Birth Risk and Maternal Nativity, Ethnicity, and Race.
Barreto A; Formanowski B; Peña MM; Salazar EG; Handley SC; Burris HH; Ortiz R; Lorch SA; Montoya-Williams D
JAMA Netw Open; 2024 Mar; 7(3):e243194. PubMed ID: 38512251
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Roberts D; Brown J; Medley N; Dalziel SR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004454. PubMed ID: 28321847
[TBL] [Abstract][Full Text] [Related]
9. Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020.
Venkatesh KK; Lynch CD; Powe CE; Costantine MM; Thung SF; Gabbe SG; Grobman WA; Landon MB
JAMA; 2022 Apr; 327(14):1356-1367. PubMed ID: 35412565
[TBL] [Abstract][Full Text] [Related]
10. Race and neonatal respiratory morbidity in the late preterm period.
Andrikopoulou M; Emeruwa UN; Ludwig E; Overton E; Gyamfi-Bannerman C
Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100408. PubMed ID: 34058419
[TBL] [Abstract][Full Text] [Related]
11. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center.
Badreldin N; Willert GG; Henricks AA; Peaceman A; Caldarelli LA; Yee LM
Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100076. PubMed ID: 32944712
[TBL] [Abstract][Full Text] [Related]
12. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
Kamath-Rayne BD; Rozance PJ; Goldenberg RL; Jobe AH
Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
[TBL] [Abstract][Full Text] [Related]
13. History of respiratory problems in prior infant and respiratory morbidity in subsequent pregnancy.
Ross N; Suresh SC; Dude A
Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100544. PubMed ID: 34875413
[TBL] [Abstract][Full Text] [Related]
14. Antenatal steroids and neonatal outcomes in late preterm births with pregestational diabetes.
Khanuja K; Jayakumaran J; Al-Kouatly HB; McLaren RA
Int J Gynaecol Obstet; 2024 Feb; ():. PubMed ID: 38340014
[TBL] [Abstract][Full Text] [Related]
15. Assessing the potential impact of extending antenatal steroids to the late preterm period.
Souter V; Kauffman E; Marshall AJ; Katon JG
Am J Obstet Gynecol; 2017 Oct; 217(4):461.e1-461.e7. PubMed ID: 28455087
[TBL] [Abstract][Full Text] [Related]
16. Improving the external validity of Antenatal Late Preterm Steroids trial findings.
Hutcheon JA; Liauw J
Paediatr Perinat Epidemiol; 2023 Jan; 37(1):1-8. PubMed ID: 34981851
[TBL] [Abstract][Full Text] [Related]
17. Euglycemia after antenatal late preterm steroids: a multicenter, randomized controlled trial.
Battarbee AN; Ye Y; Szychowski JM; Casey BM; Tita AT; Boggess KA
Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100625. PubMed ID: 35346889
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic Factors Associated with Antenatal Steroid Use among Late Preterm Births.
Clapp MA; Cohen JL; Gyamfi-Bannerman C; Kaimal AJ; Lorch SA; Wright JD; Melamed A
Am J Obstet Gynecol MFM; 2024 Jun; ():101397. PubMed ID: 38871293
[TBL] [Abstract][Full Text] [Related]
19. Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes.
Gulersen M; Gyamfi-Bannerman C; Greenman M; Lenchner E; Rochelson B; Bornstein E
Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100426. PubMed ID: 34153514
[TBL] [Abstract][Full Text] [Related]
20. Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study.
Vieira LA; Kao YH; Tsevdos DS; Lau YK; Wang Z; Li S; Zheutlin AB; Gross SJ; Stone JL; Dolan SM; Schadt EE; Li L
BMC Pregnancy Childbirth; 2022 Dec; 22(1):904. PubMed ID: 36471280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
